These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22806544)

  • 1. Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.
    Zhang L; Gao J; Li Z; Gong Y
    Dig Dis Sci; 2012 Oct; 57(10):2608-14. PubMed ID: 22806544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway.
    Xu G; Fan L; Zhao S; OuYang C
    Bioengineered; 2021 Dec; 12(1):1311-1323. PubMed ID: 33896384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro.
    Zhang L; Gao J; Li L; Li Z; Du Y; Gong Y
    Mol Biol Rep; 2011 Nov; 38(8):4903-11. PubMed ID: 21161403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms.
    Yao F; Sun M; Dong M; Jing F; Chen B; Xu H; Wang S
    Am J Med Sci; 2013 Sep; 346(3):175-80. PubMed ID: 23360791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
    Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.
    Park JK; Ryu JK; Lee KH; Lee JK; Yoon WJ; Lee SH; Yoo JW; Woo SM; Lee GY; Lee CH; Kim YT; Yoon YB
    Pancreas; 2007 Oct; 35(3):e9-15. PubMed ID: 17895837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
    Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
    Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of neuronal pentraxin II methylation in patients with pancreatic cancer: Meta-analysis.
    Huang W; Xue L; Xu H; Kong Z; Xu J; Zhao H; Nie Y
    Int J Clin Pract; 2021 Sep; 75(9):e14443. PubMed ID: 34105851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPTX2 is associated with neoadjuvant therapy response in rectal cancer.
    Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF
    J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types.
    Fu B; Guo M; Wang S; Campagna D; Luo M; Herman JG; Iacobuzio-Donahue CA
    Cancer Biol Ther; 2007 Oct; 6(10):1546-52. PubMed ID: 17912029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.
    Parsi MA; Li A; Li CP; Goggins M
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1270-8. PubMed ID: 18995218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
    Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.
    Agarwal R; Mori Y; Cheng Y; Jin Z; Olaru AV; Hamilton JP; David S; Selaru FM; Yang J; Abraham JM; Montgomery E; Morin PJ; Meltzer SJ
    PLoS One; 2009 Nov; 4(11):e8002. PubMed ID: 19956721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.
    Wang JX; He YL; Zhu ST; Yang S; Zhang ST
    World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.